Advertisement

Executive Functioning, Visuo-Spatial and Inter-Personal Skill Preservation in Alzheimer’s and Mild Cognitive Impairment

  • Sara Schatz
  • Melvin González-Rivera
Chapter
Part of the Perspectives in Pragmatics, Philosophy & Psychology book series (PEPRPHPS, volume 20)

Abstract

Most research, clinical and behavioral, has focused on cognitive degeneration, disease progression and related difficulties in Alzheimer’s disease. Additionally, most therapeutic approaches have as their goal the improvement of cognitive capacities in general. This paper discusses the case of two patients under intra-nasal insulin therapy (cf. Craft S, Baker L, Montine T, Minoshima S, Watson S, Claxton A, Arbuckle M, Callaghan M, Tsai E, Plymate S, Green P, Leverenz J, Cross D, Gerton B, Arch Neurol 69(1):29–38, 2012; de la Monte, 2012; Freiherr J, Hallschmid M, Frey II WH, Brünner YF, Chapman CD, Hölscher C, Craft S, De Felice FG, Benedict C, CNS Drugs 27:505–514, 2013; Schatz, González-Rivera, Pragmat Cognit 23(2), 2016; a.o.): an 86 year old male with moderate Alzheimer’s disease and a 67 year old male with early on-set Alzheimer’s who have both shown significant improvement of certain cognitive functions, mostly related to executive functioning and visuo-spatial skills while the elder patient exhibited severe deterioration in other capacities related to episodic memory. Selective cognitive improvement, even if partial, can have a significant impact on the quality of life of a patient and the ability to interact with others in a functional way; ameliorating some of the most devastating interactional and behavioral aspects of the disease.

References

  1. Abdelal, Ahmed M. 2015. Role of Executive Functions in Pragmatic Performance: Implications for Intervention. ASHA Annual National Convention Philadelphia, BridgeWater State University.Google Scholar
  2. Abimbola, A Akintola, van Opstal, Anna M., Westendorp, Rudi G., Iris Postmus, Jeroen van der Grond & Diana van Heemst. 2017. Effect of intranasally administered insulin on cerebral blood flow and perfusion: a randomized experiment in young and older adults. Aging 9(3):790–802.Google Scholar
  3. Alexander, Michael P. 2004. Paper presented at Cognitive Neurology Conference, Harvard Medical School.Google Scholar
  4. Alzheimer’s Association. 2016. 2016 Alzheimer’s Disease: Facts and Figures. Retrieved from: https://www.alz.org/.
  5. Alzheimer’s Foundation of America. 2017. About Alzheimer’s Disease and Dementia. Retrieved from: https://alzfdn.org/caregiving-resources/about-alzheimers-disease-and-dementia/
  6. Armstrong, R. A. 2011. The Pathogenesis of Alzheimer’s Disease: A Reevaluation of the “Amyloid Cascade Hypothesis.” International Journal of Alzheimer’s Disease, 2011, 630865.  https://doi.org/10.4061/2011/630865 CrossRefGoogle Scholar
  7. Boyd CD, Tierney M, Wassermann EM, Spina S, Oblak AL, Ghetti B, Grafman J & Huey E. 2014. Visuoperception test predicts pathologic diagnosis of Alzheimer disease in corticobasal syndrome. Neurology 83(6):510–9.CrossRefGoogle Scholar
  8. Bukar Maina, Mahmoud, Al-Hilaly, Youssra K., Serpell, Louise C. 2016. Nuclear Tau and Its Potential Role in Alzheimer’s Disease. Biomolecules 6(1).Google Scholar
  9. Chen, XQ, Fawcett, JR, Rahman, Ala, Frey II, WH. 1998. Delivery of Nerve Growth Factor to the Brain via the Olfactory Pathway. J Alzheimer’s Disease 1(1):35–44.CrossRefGoogle Scholar
  10. Clark Camilia N, Nicolas, Jennifer M., Henley, Susie M., Downey, Laura F., Golden, Hannah L., Fletcher, Phillip D. 2015. Humour understanding and expression in dementia, Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association 11(7): 396–397.CrossRefGoogle Scholar
  11. Clark, Camilia N. & Jason D. Warren. 2014. The Neurology of Humor. Advances in Clinical Neuroscience and Rehabilitation 13(7): 9–11.Google Scholar
  12. Claxton, Amy, Baker, Laura D., Hanson, Trittschuh, Emily,Angela Cholerton, Brenna Morgan, Amy Callaghan, Maureen Arbuckle, Matthew Colin Behl, Colin & Suzanne Craft. Therapeutic Effects of Intranasal Insulin and Insulin Analogues on Cognition and MRI Measures in Mild Cognitive Impairment and Alzheimer’s Disease. Alzheimer’s and Dementia 2014, 10(4):1–26Google Scholar
  13. Craft, Suzanne. HBO, The Connection The Connection between Insulin and Alzheimer’s. 2009.http://www.hbo.com/alzheimers/the-supplementary-series.html
  14. Craft, Suzanne, Claxton, Amy, Hanson, Angela, Cholerton, Brenna, Neth, Bryan, Trittschuh, Emily & Baker, Laura. Therapeutic Effects of Intranasal Insulin and Insulin Analogues on Cognition and MRI Measures in Mild Cognitive Impairment and Alzheimer’s Disease. Alzheimer’s and Dementia, 2014,10(4):1–26.Google Scholar
  15. Craft, Suzanne, Baker, Laura, Montine, Thomas, Minoshima, Satoshi, Watson, Stennis, Claxton, Amy, Arbuckle, Matthew, Callaghan, Maureen, Tsai, Elaine, Plymate, Stephen, Green, Pattie, Leverenz, James, Cross, Donna & Gerton, Brooke. Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment.Archives of Neurology,2012;Jan; 69(1):29–38.Google Scholar
  16. Davis, Boyd, Maclagan, Margeret& Cook, Julie.‘Aw: So How’s Your Day Going’? Ways that Persons with Dementia Keep their Conversational Partners Involvedin Pragmatics in Dementia Discourse, edited by Boyd H. Davis and Jacqueline Guendouzi, Cambridge: Cambridge University Scholars, 2013, pp. 83–116.Google Scholar
  17. De Jager CA, Hogervorst E, Combrinck M, Budge MM. Sensitivity and specificity of neuropsychological tests for mild cognitive impairment, vascular cognitive impairment and Alzheimer’s disease. Psychol Med,2003 Aug; 33(6):1039–50.Google Scholar
  18. de Vugt, ME, Stevens, F & Aalten P, Lousberg R, Jaspers N, Winkens I, Jolles, J and Verhey, FR. Behavioral disturbances in dementia patients and quality of the marital relationship. Int J Geriatric Psychiatry,2003; Feb;18(2):149–54.
  19. Di Santo SG, Prinelli F, Adorni F, Caltagirone C, Musicco M. A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer’s disease. J Alzheimer’s Disease, 2013;35(2):349–61.Google Scholar
  20. Freiherr, Jessica, Hallschmid, Manfred, Frey II, William H., Brünner, Yvonne F., Chapman, Colin D., Hölscher, Christian, Craft, Suzanne, De Felice, Fernanda G. & Benedict, Christian. 2013. Intranasal Insulin as a Treatment for Alzheimer’s Disease: A Review of Basic Research and Clinical Evidence. CNS Drugs 27: 505–514.CrossRefGoogle Scholar
  21. Gutiérrez, Javier & Schatz, Sara. 2016. Cognitive Impairment and Pragmatics. SpringerPlus.Google Scholar
  22. Harada, Ryuichi, Okamura, Nobuyuki et al. 2016. Characteristics of Tau and Its Ligands in PET Imaging. Biomolecules 6(1).CrossRefGoogle Scholar
  23. Hasegawa, Masato. 2016. Molecular Mechanisms in the Pathogenesis of Alzheimer’s disease and Tauopathies-Prion-Like Seeded Aggregation and Phosphorylation. Biomolecules 6(2).CrossRefGoogle Scholar
  24. Hawkins, David B& Graff-Radford, Neill R. The Ability to Pun May be Retained in Alzheimer Disease. Neurocase,2007(3):50–54.Google Scholar
  25. Lai, Robert Y. K., Harrington, Charles R., Wischik, Claude M. 2016. Absence of a Role for Phosphorylation in the Tau Pathology of Alzheimer’s Disease. Biomolecules 6(2).CrossRefGoogle Scholar
  26. Lippens, Guy, Landrieu, Isabelle et al. 2016. NMR Meets Tau: Insights into Its Function and Pathology. Biomolecules 6(2).CrossRefGoogle Scholar
  27. Matsuzono K, Hishikawa N, Ohta Y, Yamashita T, Deguchi K, Nakano Y, Abe K. 2015. Combination Therapy of Cholinesterase Inhibitor (Donepezil or Galantamine) plus Memantine in the Okayama Memantine Study. J Alzheimer’s Disease 45(3):771–80.CrossRefGoogle Scholar
  28. Medina, Miguel, Hernández, Félix, Avila, Jesús. 2016. New Features about Tau Function and Dysfunction. Biomolecules 6(2).CrossRefGoogle Scholar
  29. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM.Clinical diagnosis of Alzheimer’s disease: report of the NINCDSADRDAWork Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology, 1984;34(7):939–44.CrossRefGoogle Scholar
  30. Montgomery, RJ & Williams, KN. 2001. Implications of differential impacts of care-giving for future research on Alzheimer care. Aging & Mental Health 5(1): 23–34.CrossRefGoogle Scholar
  31. Mota-Quental, Natalia B. Brucki, Sonia Maria Dozzi & Bueno, Francisco Orlando Amodeo. Visuospatial Function in Early Alzheimer’s Disease—The Use of the Visual Object and Space Perception (VOSP) Battery. PLOS 2013, July 16; 0068398.Google Scholar
  32. Nguyen, Thanh-Phuong, Corrado Priamiand Caberlotto, Laura.Novel drug target identification for the treatment of dementia using multi-relational association mining. Scientific Reports, 2015(5),11104.Google Scholar
  33. Radanovic, Marcia, Azambuja, Mariana, Mansur, Leticia Lessa, Claudia Selitto Porto and Milberto Scaff.Thalamus an Language: Interface with attention, memory and executive functions, Arq Neuropsychiatry, 2003,61(1):34–42.Google Scholar
  34. Reger MA, Watson GS, Green PS, Baker LD, Cholerton B, Fishel MA, Plymate SR, Cherrier MM, Schellenberg GD, Frey WH 2nd, Craft S. Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults.J Alzheimer’s Disease, 2008; Apr;13(3):323–31.Google Scholar
  35. Schatz, Sara & González-Rivera, Melvin. 2016. Pragmatic function impairment and Alzheimer’s dementia. Pragmatics & Cognition 23(2).CrossRefGoogle Scholar
  36. Schmidt, H, W Kern, R Giese, M Hallschmid, A Enders. Intranasal insulin to improve developmental delay in children with 22q13 deletion syndrome: an exploratory clinical trial. J Medical Genetics, 2009 (46):217–222.CrossRefGoogle Scholar
  37. Schilling, TM, Ferreira de Sa DS, Westernhausen, R, Strelzyk, F., Larra, MF, Hallaschmid, M, Savaskan, E., Oitzl, MS, Busch, HP, Naumann, E and Schachinger, H.Intranasal insulin increases regional cerebral blood flow in the insular cortex in men independently of cortisol manipulation, Human Brain Mapping, 2014, 35:1944–56.CrossRefGoogle Scholar
  38. Silagi, Marcela Lima, Bertolucci, Paulo Henrique Ferreira & Ortiz, Karin Zazo. Naming ability in patients with mild to moderate Alzheimer’s disease: what changes occur with the evolution of the disease? Clinics (Sao Paulo) 2015,70(6); June.
  39. Šimiĉ, Goran, Babiĉ Leko, Mirjana et al. 2016. Tau Protein Hyperphosphorylation and Aggregation in Alzheimer’s Disease and Other Tauopathies, and Possible Neuroprotective Strategies. Biomolecules 6(1).CrossRefGoogle Scholar
  40. SNIF. The Study of Nasal Insulin in the Fight Against Forgetfulness. 2017.www.clinicaltrials.gov, identifier--NCT01767909.
  41. Tampi, Rajesh R. et. al. 2015. Mild cognitive impairment: A comprehensive review. Healthy Aging Research.Google Scholar
  42. Thorne RG, Emory CR, Ala TA, Frey WH Jr. Quantitative analysis of the olfactory pathway for drug delivery to the brain. Brain Research,1995(692):278–82.CrossRefGoogle Scholar
  43. Tombaugh, T.N. 2004. Trail Making test A and B: Normative Data Stratified by Age and Education. Archives of Clinical Neuropsychology,2004,19(2):203–214.CrossRefGoogle Scholar
  44. Vrticka, Pascal, Jessica M. Black & Allan L. Reiss. The Neural Basis of Humour Processing, Nature Reviews Neuroscience, 2013(14):860–868.CrossRefGoogle Scholar
  45. Wauters, Mathilde, Wattiez, Ruddy, Ris, Laurence. 2016. Internalization of the Extracellular Full-Length Tau Inside Neuro2A and Cortical Cells Is Enhanced by Phosphorylation. Biomolecules 6(3).CrossRefGoogle Scholar
  46. Winocur, Gordon. Cognitive Rehabilitation in Old Age: The Rotman Initiative, in Mind and the Frontal Lobes: Cognition, Behavior, and Brain Imaging. Publisher Oxford University Press, Editors Brian Levine, Fergus I.M. Craik, 2012, pp. 164–182.Google Scholar
  47. Wray, Alison. 2014. Formulaic language and threat: the challenge of empathy and compassion in Alzheimer’s disease interaction in Dialogue and Dementia: Cognitive and Communicative Resources for Engagement, Publisher: Psychology Press, Editors: Robert Schrauf, Nicole Mueller, pp.263–286.Google Scholar
  48. Zhao Q, Zhou B, Ding D, Teramukai S, Guo Q, Masanori Fukushima & Zhen Hong. 2014. Cognitive Decline in Patients with Alzheimer’s Disease and Its Related Factors in a Memory Clinic Setting. Shanghai, China. PLoS ONE 9(4): e95755.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Sara Schatz
    • 1
  • Melvin González-Rivera
    • 2
  1. 1.Department of International StudiesThe Ohio State UniversityColumbusUSA
  2. 2.Department of Hispanic StudiesUniversity of HoustonHoustonUSA

Personalised recommendations